Loading clinical trials...

COMPLETEDNANCT03050723

Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars

In this study, eligible patients with the medical indications (facial lipoatrophy, morphological asymmetry of the face, or debilitating scars) will be treated with Princess® FILLER, and then will retu...

Lead sponsor: Croma-Pharma GmbH•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDNA

Evaluation of HA Dermal Fillers in the Treatment of Pathological Facial Lipoatrophy

NCT05776836 · Facial Lipoatrophy (FLA)

COMPLETEDNA

Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars

NCT03050749 · Facial Lipoatrophy, Morphological Asymmetry of the Face, and more

COMPLETED

Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)

NCT00360932 · Facial Lipoatrophy

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 9, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment53

Start dateNov 2016

Last updatedDec 9, 2024

Condition

Facial Lipoatrophy Morphological Asymmetry of the Face Debilitating Scars

Locations shown

Medical University Graz

Graz

MÄZ WIEN (Medizinisch Ästhetisches Zentrum Wien)

Vienna

Ordination Dr. Benjamin Gehl

Vienna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions